Related Experiment Videos
Benzocaine-induced methemoglobinemia during general anesthesia
Summary
Benzocaine topical spray can cause methemoglobinemia, a condition leading to cyanosis during anesthesia. Prompt diagnosis and treatment with methylene blue are crucial for patient safety.
Area of Science:
- Anesthesiology
- Pharmacology
- Toxicology
Background:
- Topical anesthetics like benzocaine are commonly used in medical procedures.
- Methemoglobinemia is a rare but serious adverse effect associated with certain anesthetic agents.
Observation:
- A patient developed cyanosis during general anesthesia, unresponsive to standard interventions.
- The cyanosis was identified as methemoglobinemia, directly linked to topical benzocaine application in the pharynx and trachea.
Findings:
- Benzocaine overdose or sensitivity can induce methemoglobinemia by oxidizing hemoglobin.
- Clinical presentation includes cyanosis, especially in the absence of cardiac or pulmonary pathology.
Implications:
- Healthcare providers must consider methemoglobinemia in patients with unexplained cyanosis under anesthesia.
- Awareness of benzocaine's dosage and potential complications is vital for medical and dental professionals.
- Intravenous methylene blue is the recommended antidote for significant methemoglobinemia.